首页> 中文期刊> 《中国继续医学教育》 >沙丁胺醇联合布地奈德治疗小儿喘息性疾病发作临床效果评价

沙丁胺醇联合布地奈德治疗小儿喘息性疾病发作临床效果评价

         

摘要

Objective The paper is to observe the combined treatment of albuterol and budesonide for children with asthmatic attack.Methods 160 cases of children with asthmatic attack were taken as the research object which were divided into control group and experimental group. The children in the control group were applied with albuterol treatment, while the experimental group had the application of salbutamol joint budesonide treatment, using the same kind of atomizer. The treatment effciency, clinical symptoms disappearing time and half year relapse rate of the two groups of children were compared and analyzed.Results The treatment effciency in the experimental group was signiifcantly higher than control group, whose difficulty breathing, coughing, wheezing and other clinical symptoms disappear time was shorter than those in the control group. The recurrence rate was lower than the control group within half a year. Comparing between groups,P<0.05, which had statistically signiifcant.ConclusionThe application of combined budesonide and albuterol treatment of pediatric asthmatic diseases attack has significant clinical effect, can enhance the treatment effciency, shorten the time of clinical symptoms, and reduce the recurrence rate in half year.%目的:观察沙丁胺醇联合布地奈德治疗小儿喘息性疾病发作的临床效果。方法选取本院收治的160例喘息性疾病发作患儿作为研究对象,将160例患儿平均分成对照组和实验组,为对照组患儿应用沙丁胺醇进行治疗,实验组患儿应用沙丁胺醇联合布地奈德进行治疗,运用同一种雾化器,对两组患儿治疗有效率、临床症状消失时间以及半年内再复发情况进行对比分析。结果实验组患儿治疗有效率高于对照组患儿,呼吸困难、咳嗽、喘鸣音等临床症状消失时间比对照组患儿短,并且半年内再复发率低于对照组患儿。组间对比,P<0.05,差异具有统计学意义。结论应用沙丁胺醇联合布地奈德治疗小儿喘息性疾病发作具有显著的临床效果,能够有效提升治疗有效率,缩短临床症状消失时间,并且降低半年内疾病再复发概率。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号